CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Moonlight begins SURVEYOR Phase I trial for peanut allergy

Phase 1MOON101Positive
AI Analysis

Summary

Moonlight Therapeutics has initiated the SURVEYOR Phase I clinical trial to evaluate MOON101, an investigational immunotherapy for peanut allergy.

Clinical Trial Data

Phase

Phase 1

Importance:5/10
Sentiment:
0.30
Phase 1 TrialImmunotherapyPeanut AllergyMOON101SURVEYOR
Related Companies

Read the original article

Published by Clinical Trials Arena on June 3, 2026 8:48 AM

Read Original